Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals

Summary by CNBC
Chinese biopharma stocks rose on Monday after a report that the U.S. may continue to allow most drug licensing deals with Chinese firms.

4 Articles

CNBCCNBC
Reposted by
BizTocBizToc
Lean Left

Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals

Chinese biopharma stocks rose on Monday after a report that the U.S. may continue to allow most drug licensing deals with Chinese firms.

·Englewood Cliffs, United States
Read Full Article
sofokleousin.grsofokleousin.gr

Chinese Biopharmaceuticals: Hong Kong Rally on Hopes of US Deals

Chinese biopharmaceutical stocks rose sharply in Hong Kong on Monday as the US considered rules that would keep the door open for most licensing deals.

Read Full Article
SpaceMoneySpaceMoney

Chinese Biotech Actions Jump with U.S. Rule Under Study

Chinese biotech actions go up in Hong Kong after CNBC reports that the U.S. is studying rules to maintain drug licensing

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

CNBC broke the news in Englewood Cliffs, United States on Monday, September 21, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

China icon

China

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal